These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8983621)

  • 1. Management of premenopausal women with primary breast cancer.
    Woodman CB; Singleton J; Coyne J; Baildam A
    Br J Surg; 1996 Sep; 83(9):1256-7. PubMed ID: 8983621
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inflammatory breast cancer: clinical course, diagnosis and treatment].
    Borisov VI; Chkhikvadze TV
    Vopr Onkol; 2008; 54(1):86-9. PubMed ID: 18416065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
    Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
    Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adjuvant therapy in breast cancer].
    Semiglazov VF
    Vopr Onkol; 2000; 46(1):18-27. PubMed ID: 10789218
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclophosphamide, methotrexate and fluorouracil (CMF) versus hormonal ablation with leuprorelin acetate as adjuvant treatment of node-positive, premenopausal breast cancer patients: preliminary results of the TABLE-study (Takeda Adjuvant Breast cancer study with Leuprorelin Acetate).
    Schmid P; Untch M; Wallwiener D; Kossé V; Bondar G; Vassiljev L; Tarutinov V; Kienle E; Lüftner D; Possinger K;
    Anticancer Res; 2002; 22(4):2325-32. PubMed ID: 12174922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of single-agent and combination chemotherapy in the management of women with metastatic breast cancer.
    Love N
    Oncology (Williston Park); 2003 Apr; 17(4 Suppl 4):1-26; quiz 27-8. PubMed ID: 12736982
    [No Abstract]   [Full Text] [Related]  

  • 7. Delayed benefit of mammography screening in premenopausal women.
    Jatoi I; Soballe PW; Anderson WF
    J Clin Oncol; 2004 Dec; 22(23):4860; author reply 4860-2. PubMed ID: 15570095
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of endocrine responsiveness and HER2/neu overexpression in inflammatory breast cancer treated with multimodality preoperative therapy.
    D'Alessandro C; Dellapasqua S; Orlando L; Santoro L; Maisonneuve P; Torrisi R; Balduzzi A; Scarano E; Ghisini R; Peruzzotti G; Goldhirsch A; Colleoni M
    Breast J; 2008; 14(5):435-41. PubMed ID: 18821931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy.
    Joly F; Espié M; Marty M; Héron JF; Henry-Amar M
    Br J Cancer; 2000 Sep; 83(5):577-82. PubMed ID: 10944595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Locoregional radiotherapy after mastectomy and chemotherapy for breast cancer: prolonged survival and better local tumor control].
    Struikmans H; van Tienhoven G; Jobsen JJ; Jager JJ; Borger JH; Scheijmans LJ
    Ned Tijdschr Geneeskd; 1999 Jan; 143(2):71-3. PubMed ID: 10086106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Growth hormone and its interactions with chosen parameters of hormonal state in pre-menopausal women after mastectomy for breast cancer on adjuvant chemotherapy].
    Kajdaniuk D; Marek B; Kos-Kudła B; Buntner B; Zwirska-Korczala K; Ostrowska Z; Nowak M
    Wiad Lek; 2000; 53(5-6):283-8. PubMed ID: 10983383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effective treatment strategy in elderly breast cancer patients].
    Boér K
    Orv Hetil; 2005 Jan; 146(1):15-21. PubMed ID: 15715368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of stage I-IIA breast cancer of medial-central localization].
    Datsenko VS
    Khirurgiia (Mosk); 1998; (11):35-7. PubMed ID: 9864983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
    Weiss RB; Woolf SH; Demakos E; Holland JF; Berry DA; Falkson G; Cirrincione CT; Robbins A; Bothun S; Henderson IC; Norton L;
    J Clin Oncol; 2003 May; 21(9):1825-35. PubMed ID: 12721260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93.
    ; Colleoni M; Gelber S; Goldhirsch A; Aebi S; Castiglione-Gertsch M; Price KN; Coates AS; Gelber RD
    J Clin Oncol; 2006 Mar; 24(9):1332-41. PubMed ID: 16505417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000.
    Harlan LC; Clegg LX; Abrams J; Stevens JL; Ballard-Barbash R
    J Clin Oncol; 2006 Feb; 24(6):872-7. PubMed ID: 16484696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined ovarian ablation and aromatase inhibition as first-line therapy for hormone receptor-positive metastatic breast cancer in premenopausal women: report of three cases.
    El-Saghir NS; El-Hajj II; Makarem JA; Otrock ZK
    Anticancer Drugs; 2006 Sep; 17(8):999-1002. PubMed ID: 16940812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case 3: infiltrating ductal breast carcinoma.
    Peoples GE; Arciero C; Adair C; Shriver CD;
    Oncology (Williston Park); 2004 Apr; 18(4):437-8, 440. PubMed ID: 15134352
    [No Abstract]   [Full Text] [Related]  

  • 19. Leuprorelin acetate every-3-months depot versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant treatment in premenopausal patients with node-positive breast cancer: the TABLE study.
    Schmid P; Untch M; Kossé V; Bondar G; Vassiljev L; Tarutinov V; Lehmann U; Maubach L; Meurer J; Wallwiener D; Possinger K
    J Clin Oncol; 2007 Jun; 25(18):2509-15. PubMed ID: 17577027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
    Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N
    J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.